Data / Form D filings / VitriVax, Inc.
VitriVax, Inc.: Form D filing
VitriVax, Inc., a biotechnology company in Boulder, CO, filed a Form D with the SEC in 2025. The latest, on November 17, 2025, reports $29.4 million sold of a $37.1 million offering to 83 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5500 Central Avenue, Boulder, CO, 80301
- Phone
- (720) 503-9272
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1965109
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | New notice | $37,148,654 | $29,430,356 | $7,718,298 | 83 | Jun 30, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Glenn Rockman | Director | |
| Rene Lorenz | Director | |
| Louise Brady | Director | |
| Theodore Randolph | Director | |
| Romulo Colindres | Executive Officer, Director, Promoter |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VitriVax, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.